The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Serotonergic regulation of neuronal excitability in the prefrontal cortex
Open accessAbstract
The cerebral cortex receives a dense serotonergic innervation originating predominantly from the dorsal raphe nucleus. This innervation regulates cortical functioning by activating multiple serotonin receptors that are differentially expressed by pyramidal cells and interneurons. Electrophysiological studies in the prefrontal cortex indicate that receptors of the 5-HT(1A) and 5-HT(2A) subtypes are the main serotonin receptors regulating membrane excitability in pyramidal cells. Most pyramidal cells in layer V coexpress 5-HT(1A) and 5-HT(2A) receptors that together regulate how these neurons encode excitatory input into neuronal firing. In contrast, a subset of large pyramidal cells of deep layer V appears to express exclusively 5-HT(2A) receptors that depolarize and excite these cells. Serotonin also depolarizes and excites at least two classes of GABAergic interneurons by acting on 5-HT(3) and 5-HT(2A) receptors. The differential expression of serotonin receptors in different pyramidal cells and interneurons is consistent with a growing appreciation of the anatomical, molecular and functional heterogeneity of pyramidal cells and interneurons of the cerebral cortex. These findings begin to lay the ground for a cellular-level understanding of the serotonergic regulation of the prefrontal cortex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Psychedelics primarily act on 5-HT2ARs expressed on glutamatergic pyramidal cells in cortical and deep cortical layers (V and VI) (86, 87).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [87]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,574
Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050
Neuronal subtype specification in the cerebral cortex
Molyneaux, B. J., Arlotta, P., Menezes, J. R. L., & Macklis, J. D. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2151 · Cited by 1,704
Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles
Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., & Kurachi, Y. (2010) · Physiological Reviews · doi:10.1152/physrev.00021.2009 · Cited by 1,579
Evidence for the existence of monoamine neurons in the central nervous system
Fuxé, K. (1965) · Cell and Tissue Research · doi:10.1007/bf00337069 · Cited by 1,567
Fuxé, K. (1965) · PubMed · Cited by 1,544
Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat
Hoover, W. B., & Vertes, R. P. (2007) · Brain Structure and Function · doi:10.1007/s00429-007-0150-4 · Cited by 1,365
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult
Gross, C. T., Zhuang, X., Stark, K. L., Ramboz, S., Oosting, R. S., Kirby, L. G., Santarelli, L., Beck, S. G., & Hen, R. (2002) · Nature · doi:10.1038/416396a · Cited by 906
A G Protein Couples Serotonin and GABA B Receptors to the Same Channels in Hippocampus
Andrade, R., Malenka, R. C., & Nicoll, R. A. (1986) · Science · doi:10.1126/science.2430334 · Cited by 863
Self-citation
Cited by
Sorted by citations
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
Increased global functional connectivity correlates with LSD-induced ego dissolution
Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., Laufs, H., Leech, R., McGonigle, J., Crossley, N., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.02.010 · Cited by 503
Broadband Cortical Desynchronization Underlies the Human Psychedelic State
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2063-13.2013 · Cited by 499
The role of serotonin receptors in the action of atypical antipsychotic drugs
Meltzer, H., & Massey, B. W. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.02.007 · Cited by 390
Effects of Schedule I drug laws on neuroscience research and treatment innovation
Nutt, D., King, L. A., & Nichols, D. E. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3530 · Cited by 355
Psychedelic Psychiatry’s Brave New World
Nutt, D., Erritzøe, D., & Carhart-Harris, R. L. (2020) · Cell · doi:10.1016/j.cell.2020.03.020 · Cited by 339
de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., Hutten, N. R. P. W., Jansen, J. F. A., Stiers, P., Feilding, A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0718-8 · Cited by 258
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.041 · Cited by 230
Synaptic plasticity and mental health: methods, challenges and opportunities
Appelbaum, L. G., Shenasa, M. A., Stolz, L., & Daskalakis, Z. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01370-w · Cited by 240
Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin
Lord, L.-D., Expert, P., Atasoy, S., Roseman, L., Rapuano, K. M., Lambiotte, R., Nutt, D., Deco, G., Carhart-Harris, R. L., Kringelbach, M. L., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.05.060 · Cited by 221
Unifying Theories of Psychedelic Drug Effects
Swanson, L. R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00172 · Cited by 194
Carhart-Harris, R. L., Murphy, K., Leech, R., Erritzøe, D., Wall, M. B., Ferguson, B., Williams, L. T. J., Roseman, L., Brugger, S. P., Meer, I. D., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.015 · Cited by 187
Serotonin neurons modulate learning rate through uncertainty
Grossman, C. D., Bari, B. A., & Cohen, J. Y. (2022) · Current Biology · doi:10.1016/j.cub.2021.12.006 · Cited by 164
Fogaça, M. V., Reis, F. M. C. V., Campos, A. C., & Guimarães, F. S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.012 · Cited by 153
Brouwer, A., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120959637 · Cited by 174
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Asan, E., Steinke, M. R., & Lesch, K. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1081-1 · Cited by 142
LSD modulates music-induced imagery via changes in parahippocampal connectivity
Kaelen, M., Roseman, L., Kahan, J., Santos-Ribeiro, A., Orbán, C., Lorenz, R., Barrett, F. S., Bolstridge, M., Williams, T., Williams, L., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.018 · Cited by 135
Control of Intermale Aggression by Medial Prefrontal Cortex Activation in the Mouse
Takahashi, A., Nagayasu, K., Nishitani, N., Kaneko, S., & Koide, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094657 · Cited by 123
Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.-U., Volz, H.-P., & Riedel, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0079-5 · Cited by 112
Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics
Meltzer, H. Y. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_4 · Cited by 97
Varley, T. F., Carhart-Harris, R. L., Roseman, L., Menon, D. K., & Stamatakis, E. A. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117049 · Cited by 91
Pehrson, A. L., Leiser, S. C., Gulinello, M. E., Dale, E., Li, Y., Waller, J. A., & Sánchez, C. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.044 · Cited by 98
Geddes, S. D., Assadzada, S., Lemelin, D., Sokolovski, A., Bergeron, R., Haj-Dahmane, S., & Béïque, J.-C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522754113 · Cited by 90
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Stoliker, D., Egan, G. F., Friston, K. J., & Razi, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000508 · Cited by 96
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
Corrigan, K., Haran, M., McCandliss, C., McManus, R., Cleary, S., Trant, R., Kelly, Y., Ledden, K., Rush, G., O’Keane, V., et al. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02668-2 · Cited by 84
Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players
Meunier, C. N. J., Chameau, P. J. P., & Fossier, P. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00002 · Cited by 86
Bekinschtein, P., Renner, M. C., Gonzalez, M. C., & Weisstaub, N. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2087-13.2013 · Cited by 69
Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
Elucidating the Mechanism of Action of Pregabalin
Micó, J. A., & Prieto, R. (2012) · CNS Drugs · doi:10.2165/11634510-000000000-00000 · Cited by 66
Komlósi, G., Molnár, G., Rózsa, M., Oláh, S., Barzó, P., & Tamás, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2618-12.2012 · Cited by 57
Roberts, C., Sahakian, B. J., & Robbins, T. W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.001 · Cited by 63
Smausz, R., Neill, J. C., & Gigg, J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221092508 · Cited by 65
Atasoy, S., Vohryzek, J., Deco, G., Carhart-Harris, R. L., & Kringelbach, M. L. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.009 · Cited by 59
Li, Y., Raaby, K. F., Sánchez, C., & Gulinello, M. E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.09.002 · Cited by 61
Elliott, M. C., Tanaka, P. M., Schwark, R., & Andrade, R. (2018) · eNeuro · doi:10.1523/eneuro.0305-17.2018 · Cited by 57
Self-citationAqil, M., & Roseman, L. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109300 · Cited by 63
Burt, J. B., Preller, K. H., Demirtaş, M., Ji, J. L., Krystal, J. H., Vollenweider, F. X., Anticevic, A., & Murray, J. D. (2021) · eLife · doi:10.7554/elife.69320 · Cited by 48
Effects of pregabalin on sleep in generalized anxiety disorder
Holsboer‐Trachsler, E., & Prieto, R. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000922 · Cited by 53
Perrenoud, Q., Rossier, J., Férézou, I., Geoffroy, H., Gallopin, T., Vitalis, T., & Rancillac, A. (2012) · Frontiers in Neural Circuits · doi:10.3389/fncir.2012.00050 · Cited by 57
Wolf, G., Singh, S., Blakolmer, K., Lerer, L. B., Lifschytz, T., Heresco‐Levy, U., Lotan, A., & Lerer, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01832-z · Cited by 51
Sizemore, T. R., & Dacks, A. M. (2016) · Scientific Reports · doi:10.1038/srep37119 · Cited by 48
5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux
Huang, M., Horiguchi, M., Felix, A. R., & Meltzer, H. Y. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328352de40 · Cited by 45
Ferreira, S. G., Teixeira, F. M., Garção, P., Agostinho, P. M., Ledent, C. A., Cortes, L., Mackie, K., & Köfalvi, A. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.009 · Cited by 43
Canal, C. E., Felsing, D. E., Liu, Y., Zhu, W., Wood, J. T., Perry, C. K., Vemula, R., & Booth, R. G. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00099 · Cited by 43
Mikail, H. G., Dalla, C., Kokras, N., Kafetzopoulos, V., & Papadopoulou‐Daifoti, Z. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.06.016 · Cited by 42
Are psychedelics the answer to chronic pain: A review of current literature
Kooijman, N. I., Willegers, T., Reuser, A. M., Mulleners, W. M., Kramers, C., Vissers, K. C. P., & van der Wal, S. E. I. (2023) · Pain Practice · doi:10.1111/papr.13203 · Cited by 47
Rask‐Andersen, M., Jacobsson, J. A., Moschonis, G., Chavan, R. A., Sikder, M. A. N., Allzén, E., Alsiö, J., Chrousos, G. P., Μanios, Y., Fredriksson, R., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.176 · Cited by 37
Spain, A., Howarth, C., Khrapitchev, A. A., Sharp, T., Sibson, N. R., & Martin, C. J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.018 · Cited by 37
Meunier, C. N. J., Amar, M., Lanfumey, L., Hamon, M., & Fossier, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.003 · Cited by 35
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Artin, H., Zisook, S., & Ramanathan, D. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i6.201 · Cited by 33
West, A. M., Best, J. A., Abdalla, A., Nijhout, H. F., Reed, M. C., & Hashemi, P. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.004 · Cited by 33
Isbell, E., Stevens, C., Pakulak, E., Wray, A. H., Bell, T. A., & Neville, H. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707241114 · Cited by 37
Serotonergic neuromodulation of synaptic plasticity
Higa, G. S. V., Viana, F. J. C., Francis-Oliveira, J., Cruvinel, E., Franchin, T. S., Marcourakis, T., Ulrich, H., & De Pasquale, R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110036 · Cited by 29
Acute restraint differently alters defensive responses and fos immunoreactivity in the rat brain
de Andrade, J. S., Abrão, R. O., Céspedes, I. C., Garcia, M. C., Nascimento, J. O. G., Spadari-Bratfisch, R. C., Melo, L. L., da Silva, R. C. B., & Viana, M. D. B. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.034 · Cited by 29
Soriani, O., & Kourrich, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01186 · Cited by 29
Oyamada, Y., Horiguchi, M., Rajagopal, L., Miyauchi, M., & Meltzer, H. Y. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.040 · Cited by 30
A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex
Luppi, A. I., Girn, M., Rosas, F. E., Timmermann, C., Roseman, L., Erritzøe, D., Nutt, D., Stamatakis, E. A., Spreng, R. N., Xing, L., et al. (2023) · Brain · doi:10.1093/brain/awad311 · Cited by 31
Liao, C., & Lee, L. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.09.028 · Cited by 28
Armstrong, J. L., Casey, A. B., Saraf, T. S., Mukherjee, M., Booth, R. G., & Canal, C. E. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00101 · Cited by 26
Werle, I., Nascimento, L. M. M., dos Santos, A. L. A., Soares, L. A., SANTOS, R. G. D., Hallak, J. E. C., & Bertoglio, L. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16315 · Cited by 28
ΔFosB Decreases Excitability of Dorsal Hippocampal CA1 Neurons
Eagle, A. L., WILLIAMS, E. S., Beatty, J. A., Cox, C. L., & Robison, A. J. (2018) · eNeuro · doi:10.1523/eneuro.0104-18.2018 · Cited by 25
Eickelbeck, D., Karapinar, R., Jäck, A., Süß, S. T., Barzan, R., Azimi, Z., Surdin, T., Grömmke, M., Mark, M. D., Gerwert, K. B., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0292-y · Cited by 27
Hammo, A., Wisser, S., & Cichon, J. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02068-0 · Cited by 25
Padawer-Curry, J. A., Krentzman, O. J., Kuo, C., Wang, X., Bice, A. R., Nicol, G. E., Snyder, A. Z., Siegel, J. S., McCall, J. G., & Bauer, A. Q. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02069-z · Cited by 30
Delint‐Ramírez, I., García‐Oscos, F., Segev, A., & Kourrich, S. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0092-7 · Cited by 23
Olusakin, J., Moutkine, I., Dumas, S., Ponimaskin, E. G., Païzanis, E., Soiza‐Reilly, M., & Gaspar, P. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0775-z · Cited by 27
Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical study
Wang, D., & Wong‐Lin, K. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00054 · Cited by 24
5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction
Nakao, K., Singh, M., Sapkota, K., Fitzgerald, A., Hablitz, J. J., & Nakazawa, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01930-0 · Cited by 21
Dacks, A. M., Reale, V., Pi, Y., Zhang, W., Dacks, J. B., Nighorn, A. J., & Evans, P. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069422 · Cited by 24
Harkin, E. F., Lynn, M. B., Payeur, A., Boucher, J.-F., Caya-Bissonnette, L., Cyr, D., Stewart, C. A., Longtin, A., Naud, R., & Béïque, J.-C. (2023) · eLife · doi:10.7554/elife.72951 · Cited by 21
Frick, L. R., Bernardez-Vidal, M., Höcht, C., Zanutto, B. S., & Rapanelli, M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.025 · Cited by 22
Singh, N., Hazari, P. P., Mittal, P., Yadav, S. K., Kumar, N., Mishra, G., Dahiya, S., & Mishra, A. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177737 · Cited by 24
Serotonergic Regulation in Alzheimer’s Disease
Долгачева, Л. П., Зинченко, В. П., Nadeev, A. D., & Goncharov, N. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115218 · Cited by 21
Zhang, M., Li, R., Wang, Y., & Huang, Z. (2017) · Neural Plasticity · doi:10.1155/2017/5870735 · Cited by 19
Pizzi, S. D., Chiacchiaretta, P., Sestieri, C., Ferretti, A., ONOFRJ, M. C., Penna, S. D., Roseman, L., Timmermann, C., Nutt, D. J., Carhart-Harris, R. L., et al. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.03.009 · Cited by 19
Neural Geometrodynamics, Complexity, and Plasticity: A Psychedelics Perspective
Ruffini, G., Lopez-Sola, E., Vohryzek, J., & Sanchez-Todo, R. (2024) · Entropy · doi:10.3390/e26010090 · Cited by 17
Alexander, G. M., Graef, J. D., Hammarback, J. A., Nordskog, B. K., Burnett, E. J., Daunais, J. B., Bennett, A. J., Friedman, D. P., Suomi, S. J., & Godwin, D. W. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.027 · Cited by 19
Hassan, S. F., Zumut, S., Burke, P. G. R., McMullan, S., Cornish, J. L., & Goodchild, A. K. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.028 · Cited by 17
Puzerey, P. A., Decker, M. J., & Galán, R. F. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00031.2014 · Cited by 16
Effects of LSD on music-evoked brain activityPreprint
Kaelen, M., Lorenz, R., Barrett, F. S., Roseman, L., Orbán, C., Santos-Ribeiro, A., Wall, M. B., Feilding, A., Nutt, D. J., Muthukumaraswamy, S. D., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/153031 · Cited by 19
Psilocybin as a novel treatment for chronic pain
Askey, T., Lasrado, R., Maiarù, M., & Stephens, G. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17420 · Cited by 18
Ionescu, T. M., Amend, M., Watabe, T., Hatazawa, J., Maurer, A., Reischl, G., Pichler, B. J., Wehrl, H. F., & Herfert, K. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264391 · Cited by 16
Bridging the gap between single receptor type activity and whole‐brain dynamics
Jancke, D., Herlitze, S., Kringelbach, M. L., & Deco, G. (2021) · FEBS Journal · doi:10.1111/febs.15855 · Cited by 17
Cadeddu, R., Ibba, M., Sadile, A. G., & Carboni, E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3335-y · Cited by 16
Yin, L., Yu, Y., Han, F., & Wang, Q. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae258 · Cited by 16
Ruffini, G., Castaldo, F., Lopez-Sola, E., Sanchez-Todo, R., & Vohryzek, J. (2024) · Entropy · doi:10.3390/e26110953 · Cited by 20
5-HT2A Receptors and BDNF Regulation: Implications for Psychopathology
Jaggar, M., & Vaidya, V. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_17 · Cited by 15
Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
Munafò, A., Arillotta, D., Mannaioni, G., Schifano, F., Bernardini, R., & Cantarella, G. (2022) · Pharmaceuticals · doi:10.3390/ph16010068 · Cited by 15
Armenta-Reséndiz, M., Cruz, S. L., & Galván, E. J. (2018) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2018.04.006 · Cited by 15
Serotonergic Modulation of the Excitation/Inhibition Balance in the Visual Cortex
Carlos-Lima, E., Higa, G. S. V., Viana, F. J. C., Tamais, A. M., Cruvinel, E., Borges, F. S., de Oliveira, J. F., Ulrich, H., & Pasquale, R. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010519 · Cited by 12
Eriksson, O., Wall, A. E., Olsson, U., Marteinsdóttir, Í., Holstad, M., Ågren, H., Hartvig, P., Långström, B., & Naessén, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159538 · Cited by 13
Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives
Czopek, A., Jończyk, J., Fryc, M., Kluzik, D., & Zagórska, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00152 · Cited by 14
Tejeda-Martínez, A. R., Ramos-Molina, A. R., Rubalcava, P. A. B., & Flores-Soto, M. E. (2024) · Medicine · doi:10.1097/md.0000000000038943 · Cited by 13
Antonijevic, M., Dallemagne, P., & Rochais, C. (2024) · Medicinal Research Reviews · doi:10.1002/med.22075 · Cited by 12
Baeken, C., Bossuyt, A. M., & Raedt, R. D. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.12.005 · Cited by 10
Saitow, F., Takumi, T., & Suzuki, H. (2020) · Molecular Brain · doi:10.1186/s13041-020-00655-9 · Cited by 12
Metadata
- Authors
- Andrade, R.
- Affiliations
- Wayne State University (US)
- Corresponding author
- Andrade, Rodrigo
- ORCID
- Andrade, Rodrigo
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 61
- Issue
- 3
- Pages
- 382-386
- ISSN
- 0028-3908 (ISSN-L)
- PMC
- PMC3110517
- OpenAlex
- W1990926259
- Cited by
- 167
- References
- 48
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 9 · 2022: 14 · 2021: 11 · 2020: 10 · 2019: 7 · 2018: 9 · 2017: 8 · 2016: 9 · 2015: 8 · 2014: 9 · 2013: 13 · 2012: 12
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Intellectum (Universidad de La Sabana) (submittedVersion, other-oa)
- Funders
- NIH grant (MH43987)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural dynamics and brain function
- Keywords
- serotonin, prefrontal cortex, neuronal excitability, dorsal raphe nucleus, 5-HT1A receptor, 5-HT2A receptor, 5-HT3 receptor, pyramidal neurons, GABAergic interneurons, cortical layer V, receptor heterogeneity, cortical excitability
- MeSH terms
- Animals, gamma-Aminobutyric Acid, Humans, Interneurons, Nerve Tissue Proteins, Synaptic Transmission, Neurons, Receptors, Serotonin, Serotonin, Prefrontal Cortex, Pyramidal Cells, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review